Daily Care News for March 14, 2023
advertisement
- Insulin edema, a little known entity
- Comparison of regular with NPH insulin vs. premix insulin in children and adolescents with type 1 diabetes in a resources-limited setting: a retrospective data analysis
- Psychological consequences of the COVID-19 pandemic in people with type 1 diabetes: A systematic literature review
- Ramadan fasting and type 1 diabetes: a scoping review protocol
- Early Gastrointestinal Neuropathy Assessed by Wireless Motility Capsules in Adolescents with Type 1 Diabetes (Full text HTML, PDF)
- Protein intake and postprandial hyperglycemia in children and adolescents with type 1 diabetes mellitus, a pilot study
- Efficacy of unblinded and blinded intermittently scanned continuous glucose monitoring for glycemic control in adults with type 1 diabetes
- Risk factors for pre-clinical atherosclerosis in adolescents with type 1 diabetes
- Updated Psychosocial Surveys With Continuous Glucose Monitoring Items for Youth With Type 1 Diabetes and Their Caregivers
- Evaluating the influence of sleep quality and quantity on glycemic control in adults with type 1 diabetes
- Emerging drugs for the treatment of type 1 diabetes mellitus: a review of phase 2 clinical trials
- Narrowing the Divide: The Role of Telehealth in Type 1 Diabetes Care for Marginalized Communities
- Insulin Glargine in Type 1 Diabetes Mellitus: A Review of Clinical Trials and Real-world Evidence Across Two Decades
- A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory Study
- 24-Hour Movement Behaviours (Physical Activity, Sedentary Behaviour and Sleep) Association with Glycaemic Control and Psychosocial Outcomes in Adolescents with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Studies
- Association between Toxoplasma gondii Infection and Type-1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- Empagliflozin as adjunctive therapy improves time in range in type 1 diabetes
- CGM metrics comparable in type 1 diabetes with insulin glargine, insulin degludec
